Agendia Bv
Agendia's MammaPrint Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
Published in Oncology Business Week, January 4th, 2009
announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer.
Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session Molecular profiling for guiding therapeutic decisions. The study analyzed the association between the pathological complete response
(pCR) rate and the results of the MammaPrint test.
"Physicians are increasingly supportive of MammaPrint in clinical practice because they believe it provides them...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Agendia Bv
Agendia's Breast Cancer Test MammaPrint Identifies New Subset of Low Risk HER2+ Patients - Angiogenesis
OmegaGenesis Announces Angiogenesis Application Collaboration - Beliefnet.com
Beliefnet's Most Inspiring Person of the Year Honor Goes to Professor Randy Pausch - Biotech Business
MedNet Solutions Wrapping up Banner Year With Six New Studies Going Live in December - Breast Cancer
The Rose's Breast Health Collaborative of Texas Wins National Award for Best Practices in Breast Cancer Advocacy - Breast Cancer
The Western Community Shows Its Heart by Wearing Pink! - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
